Cisatracurium Besylate 00781-3150
Product NDC
00781-3150- Manufacturer
- Sandoz Inc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 16, 2012
- Listing Expires
- December 31, 2026
- Application
- ANDA200154
Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cisatracurium Besylate | 2 mg/mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Packaging Options(1)
10 BOX in 1 CARTON (0781-3150-95) / 1 VIAL in 1 BOX (0781-3150-75) / 5 mL in 1 VIAL